NCT04400474 2025-06-19CABATENGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed93 enrolled 17 charts
NCT04197310 2025-01-31Cabozantinib and Nivolumab for Carcinoid TumorsDana-Farber Cancer InstitutePhase 2 Completed19 enrolled 10 charts